- Home
- LNC vs HALO Comparison
LNC vs HALO Comparison
Compare LNC & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNC | HALO |
|---|---|---|
| Founded | 1905 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.8B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | LNC | HALO |
|---|---|---|
| Price | $39.90 | $70.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 11 |
| Target Price | $45.92 | ★ $78.18 |
| AVG Volume (30 Days) | 1.8M | ★ 2.1M |
| Earning Date | 01-01-0001 | 05-10-2026 |
| Dividend Yield | ★ 4.49% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.56 |
| Revenue | N/A | ★ $151,862,000.00 |
| Revenue This Year | $11.29 | $28.38 |
| Revenue Next Year | $3.74 | $12.72 |
| P/E Ratio | ★ $7.17 | $27.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.58 | $47.50 |
| 52 Week High | $46.82 | $82.22 |
Technical Indicators
Market Signals| Indicator | LNC | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 42.91 | 42.94 |
| Support Level | $39.65 | $71.04 |
| Resistance Level | $42.25 | $81.51 |
| Average True Range (ATR) | 1.39 | 2.73 |
| MACD | 0.11 | -0.90 |
| Stochastic Oscillator | 27.21 | 5.37 |
Price Performance
Historical ComparisonAbout LNC Lincoln National Corporation
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.